Finance Home - My Yahoo - Yahoo! - Help

Tuesday, November 10, 2009, 12:46PM ET - U.S. Markets close in 3 hours and 14 minutes. Dow  0.20% Nasdaq  0.44%

Impax Laboratories Inc. (IPXL)

At 12:30PM ET: 9.89   0.14 (1.44%)

MORE ON IPXL

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Tue, Nov 10, 2009 • IMPAX LABORATORIES INC Financials EDGAR Online Financials (Tue 9:04am) Fri, Nov 6, 2009 • Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors Wall Street Transcript (Fri, Nov 6) Thu, Nov 5, 2009 • [$$] Should You Buy It? Impax Labs at RealMoney by TheStreet.com (Thu, Nov 5) Wed, Nov 4, 2009 • IMPAX LABORATORIES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Nov 4) • New Star Analyst Rankings for Impax Laboratories, Inc. StarMine (Wed, Nov 4) Tue, Nov 3, 2009 • Impax swings to Q3 profit at bizjournals.com (Tue, Nov 3) • Impax Laboratories Earnings Call scheduled for 11:00 am ET today CCBN (Tue, Nov 3) • IMPAX LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Tue, Nov 3) • Impax Laboratories Continues Trend of Solid Growth in Revenue, Profit and Earnings for the Third Quarter 2009 Business Wire (Tue, Nov 3) • Q3 2009 Impax Laboratories Earnings Release - Before Market Open CCBN (Tue, Nov 3) Fri, Oct 30, 2009 • Abbott suing Impax Labs over generic TriCor AP (Fri, Oct 30) • Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets Business Wire (Fri, Oct 30) Mon, Oct 26, 2009 • Impax starts second Parkinson’s trial at bizjournals.com (Mon, Oct 26) • Impax Pharmaceuticals Initiates Second Phase III Trial of IPX066 in Parkinson's Disease Business Wire (Mon, Oct 26) Tue, Oct 20, 2009 • New Formulation Of Diclofenac Successful In Two Phase III Trials, Approval Will Be Catalyst For Stock According To Industry Expert Wall Street Transcript (Tue, Oct 20) Tue, Oct 13, 2009 • Impax Laboratories to Host Third Quarter 2009 Earnings Conference Call and Webcast on November 3 Business Wire (Tue, Oct 13) • Shire and Sandoz settle Adderall XR patent suits AP (Tue, Oct 13) Wed, Oct 7, 2009 • Impax settles suit with Astellas, Boehringer at bizjournals.com (Wed, Oct 7) • Impax Laboratories Settles Pending Litigation for FLOMAX® Business Wire (Wed, Oct 7) Mon, Oct 5, 2009 • Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX® 0.4mg Capsules Business Wire (Mon, Oct 5) Older Headlines - Download Recent Headlines View headlines from: Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009Mon, Sep 7, 2009Mon, Aug 31, 2009Mon, Aug 24, 2009Mon, Aug 17, 2009Mon, Aug 10, 2009Mon, Aug 3, 2009 Add IPXL News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage